Table 3. Comparison of survival outcomes (ALND vs. SLNB).

Trial/author	Axillary recurrences (%)	Disease-free survival (%)	Overall survival (%)
Veronesi et al. [33]	0 vs. 0.01	88.8 vs. 89.9 (10 yr)*	89.7 vs. 93.5 (10 yr)†
ALMANAC [25]	0.84 vs. 0.2 (1 yr)	NR	NR
Sentinella-GIVOM [30]	0.05 vs. 0.01	89.9 vs. 87.6	95.5 vs. 94.8
Canavese et al. [29]	0.87 vs. 0.0	89.8 vs. 94.5‡	97.2 vs. 97.2§
NSABP B-32 [34]	0.1 vs. 0.3	82.4 vs. 81.5 (8 yr)	91.8 vs. 90.3 (8 yr)

ALND=axillary lymph node dissection; SLNB=sentinel lymph node biopsy; NR=not reported.

^*p=0.52; ^†p=0.15; ^‡p=0.715; ^§p=0.697.